SCHEMBL7991645

SCHEMBL7991645

O=c1[nH]c(-c2cccc(O)c2)nc2ncn(Cc3cccc(Cl)c3)c12

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.47
ALDH1A1 P00352 2/20 0.47
HPGD P15428 1/20 0.45
GLA P06280 1/20 0.44
HTT P42858 1/20 0.44
UBE2N P61088 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KMT2A Q03164 1/20 0.44
ACP1 P24666 2/20 0.41
EGLN1 Q9GZT9 1/20 0.41
MKNK1 Q9BUB5 1/20 0.39
MKNK2 Q9HBH9 1/20 0.39
FSCN1 Q16658 1/20 0.39
TOP2A P11388 1/20 0.39
YTHDC1 Q96MU7 1/20 0.38
MAPK1 P28482 1/20 0.38
PIN1 Q13526 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7973624 0.93 SMN1; SMN2 (0.48) SMN1; SMN2ALDH1A1HPGDGLAHTT
SCHEMBL7985332 0.92 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1HPGDKMT2A
SCHEMBL7988662 0.90 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1HPGDGLAHTT
SCHEMBL7991564 0.89 SMN1; SMN2 (0.45) SMN1; SMN2ALDH1A1HPGDGLAHTT
SCHEMBL7974010 0.89 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1HPGDGLAHTT
SCHEMBL7974245 0.88 HPGD (0.45) SMN1; SMN2ALDH1A1HPGDHTTKMT2A
SCHEMBL7991634 0.88 ALDH1A1 (0.45) SMN1; SMN2ALDH1A1HPGDKMT2AACP1
SCHEMBL7987307 0.88 GRIN1 (0.46) SMN1; SMN2ALDH1A1HPGDGLAHTT
SCHEMBL7985609 0.87 ALDH1A1 (0.45) SMN1; SMN2ALDH1A1HPGDKMT2AACP1
SCHEMBL7985561 0.87 HPGD (0.46) SMN1; SMN2ALDH1A1HPGDKMT2AACP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed